Efficacy and Cost-Effectiveness of Low-Dose vs Standard Dose Prophylaxis for Hemophilia in Indonesia: A Systematic Review.

J Blood Med · 2025 · PMC12056522 · PMID 40336790

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

quite significantno p-value reported

20 Although higher-dose prophylaxis may show prominent advantage in ABR, the clinical impact of the LDP is quite significant and hence clinically effective as a viable non-inferior strategy for the patients.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.